Neurocrine Biosciences Inc expected to post earnings of $1.51 a share - Earnings Preview

Neurocrine Biosciences

28/10/2024 13:00

* Neurocrine Biosciences Inc  NBIX.OQ   NBIX.O  is expected
to show a rise in quarterly revenue when it reports  results on
October 30 for the period ending September 30 2024
    * The San Diego California-based  company is expected to
report a
20.4% increase in revenue to $600.628 million from $498.8
million a year ago, according to the mean estimate from 24
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Neurocrine Biosciences
Inc is
for earnings of $1.51 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 24 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neurocrine
Biosciences Inc is $168.00​, above​ its last closing price
of $116.08. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   1.02        1.05       0.63      Missed  -40.2
 Mar. 31 0001  0.97        1.01       0.42      Missed  -58.4
 Dec. 31 2023  1.27        1.15       1.44      Beat    25.7​
 Sep. 30 2023  0.98        0.97       0.82      Missed  -15.1
 ​​Jun.        0.83        0.78       0.95      Beat    22.2
 30 2023                                                
 Mar. 31 2023  -0.53       0.13       -0.79     Missed  -709.2
                                                        ​
 Dec. 31 2022  1.11        1.16       0.88      Missed  -23.8
 Sep. 30 2022  0.83        0.79       0.69      Missed  -13.2
 This summary was machine generated October 28 at 13:00 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)